Rock Springs Capital Management LP Beam Therapeutics Inc. Transaction History
Rock Springs Capital Management LP
- $2.51 Billion
- Q4 2024
A detailed history of Rock Springs Capital Management LP transactions in Beam Therapeutics Inc. stock. As of the latest transaction made, Rock Springs Capital Management LP holds 252,223 shares of BEAM stock, worth $6.48 Million. This represents 0.25% of its overall portfolio holdings.
Number of Shares
252,223
Previous 249,923
0.92%
Holding current value
$6.48 Million
Previous $6.12 Million
2.16%
% of portfolio
0.25%
Previous 0.21%
Shares
4 transactions
Others Institutions Holding BEAM
# of Institutions
253Shares Held
78.6MCall Options Held
304KPut Options Held
142K-
Farallon Capital Management LLC San Francisco, CA8.24MShares$212 Million1.09% of portfolio
-
Black Rock Inc. New York, NY7.63MShares$196 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA7.62MShares$196 Million0.0% of portfolio
-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl7.07MShares$182 Million1.53% of portfolio
-
Arch Venture Management, LLC Chicago, IL4.54MShares$117 Million70.85% of portfolio
About Beam Therapeutics Inc.
- Ticker BEAM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 70,354,600
- Market Cap $1.81B
- Description
- Beam Therapeutics Inc., a biotechnology company, develops precision genetic medicines for patients suffering from serious diseases in the United States. The company is developing BEAM-101 for the treatment of sickle cell disease and beta thalassemia; BEAM-102 for the treatment of sickle cell disease; and BEAM-201, an allogeneic chimeric antigen ...